Correction to: A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

Abstract

The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández in the original article.

The original version of this article was revised: The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández.

https://ift.tt/2J4hVBi